| Dynamic Therapy Services, Llc | |
|
37155 Rehoboth Avenue Ext, Rehoboth Beach, DE 19971-3194 | |
| (302) 227-2008 | |
| (302) 227-8098 |
| Full Name | Dynamic Therapy Services, Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 37155 Rehoboth Avenue Ext, Rehoboth Beach, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225637051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Secondary |
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dynamic Therapy Services, Llc 350 New Fidelity Ct, Garner, NC 27529-2665 Ph: (919) 258-2714 | Dynamic Therapy Services, Llc 37155 Rehoboth Avenue Ext, Rehoboth Beach, DE 19971-3194 Ph: (302) 227-2008 |
News Archive
The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.
The results of two studies presented today at the Annual European Congress of Rheumatology provide insight into the role of sleep in chronic pain.
Unless we make hard decisions now, in less than a decade every dollar of federal revenue will go to covering the costs of Medicare, Social Security and interest payments on our debt. ... I admire Congressman Paul Ryan's honest attempt to save Medicare.
Researchers from Canada and Australia have found that the use of remote monitoring for patients with chronic heart failure has the potential to significantly improve clinical outcomes (mortality, morbidity and quality indicators).
Sequella, a clinical-stage pharmaceutical company commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it has licensed Pfizer Inc's exclusive worldwide rights to develop and commercialize sutezolid, a Phase 2 oxazolidinone antibiotic currently in development for the treatment of tuberculosis.
› Verified 7 days ago
Roberta Wasilko, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19266 Coastal Hwy, Shops At Sea Coast, Rehoboth Beach, DE 19971 Phone: 302-226-2230 | |
Shelby Moore, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 19266 Coastal Hwy, Rehoboth Beach, DE 19971 Phone: 302-226-2230 Fax: 302-227-7065 |